Published Research May 10, 2023 Innovative treatment for prostate cancer shows long-term success Prostate cancer is the second most common cancer in men and the fifth leading cause of cancer death worldwide. Despite decades of research and multiple treatment options including chemo and hormone therapies, many patients still experience worsening disease and develop metastatic castration-resistant prostate cancer (mCRPC), which is typically fatal. Providing these patients with access to improved treatments may help them to survive longer and improve their quality of life. PHM’s research has been published in the peer-reviewed publication “Frontiers in Oncology.” In this case report, we summarize the treatment course for a 73-year-old male patient, who came to PHM for assistance in managing his mCRPC. Read More
Ask Our Experts April 27, 2023 Women’s heart health risk: 1 in 3 deaths each year Cardiovascular diseases, including heart attack and stroke, cause 1 in 3 deaths in women each year1. Some symptoms that women commonly experience during a heart attack are more subtle than the “classic” male symptoms. As a result, many women may not realize they are having a cardiovascular emergency and fail to seek treatment. Here, PHM share valuable information about heart attack and strokes in women, including new tools that are available for managing your heart health, along with symptoms, prevention, and risk management. Read More
Ask Our Experts April 27, 2023 What to Know About a “Breakthrough” Weight Loss Drugs The drugs, Wegovy® and Ozempic® have been in the news and trending on social media due to their unprecedented success in helping people lose large amounts of weight. Our experts at PHM answer some common questions about the recently FDA approved drug, Wegovy. Read More
Published Research April 27, 2023 Actions for employers to mitigate cancer risk Advancements in cancer care over the past 20 years have been transformational, driven by updated recommendations in cancer screening, emergence of molecular diagnostic tools to guide treatments, and the development of cutting-edge therapeutics. Each offers the potential for better outcomes, but employers are faced with the challenge of ensuring these often costly tools and treatments are used effectively. In the newly published whitepaper, "Managing Cancer Care in Your Health Plan," Private Health Management (PHM) and Springbuk experts provide insights for employers to improve cancer outcomes and optimize cancer spend. Download the whitepaper now. Read More
News April 26, 2023 Employers can play a significant role in closing the clinical quality gap in cancer In the 2023 "Managing Cancer Care in Your Health Plan" whitepaper, PHM brings clinical insights to Springbuk's claims data from more than 1,000 select employers consisting of 1.7 million lives covered. The paper identifies three areas of opportunities for companies to: Encourage prevention through advanced screenings to achieve better health outcomes at lower treatment costs. Enable molecular profiling, still highly underutilized, to ensure cancers are appropriately characterized and individuals are benefiting from the latest in precision medicine. Optimize drug spend by making informed formulary decisions, not merely restricting use of high-cost drugs. Read More
Podcasts April 17, 2023 Sophisticated Solutions for Complex Cancer Care In the latest episode of the Springbuk podcast, Natalya Gertsik, Ph.D., Vice President, ClearCancer Solution Management, at Private Health Management, and a contributor to the 2023 Springbuk Employee Health Trends report, joins Jennifer Jones and Mike Pattengale to chat through sophisticated solutions for complex cancer care. Read More
